GH-Releasing Peptides Improve Heart Function, Fight Cachexia, AND Reduce Heart Cell Death

GH-releasing peptides improved cardiac dysfunction, reversed cachexia (muscle wasting), suppressed stress hormones, and reduced cardiomyocyte apoptosis in heart failure — demonstrating quadruple cardiac benefit.

Xu, Xiang-Bin et al.·American journal of physiology. Heart and circulatory physiology·2005·Preliminary EvidenceAnimal StudyAnimal Study
RPEP-01102Animal StudyPreliminary Evidence2005RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Animal Study
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

GH-releasing peptides in heart failure models improved cardiac contractility, reversed cachexia, suppressed stress hormones (norepinephrine, cortisol), and reduced cardiomyocyte apoptosis — quadruple mechanism benefit addressing four major heart failure components.

Key Numbers

How They Did This

animal-study study on ghrp, cardiovascular.

Why This Research Matters

Relevant for ghrp, cardiovascular, hormone-optimization.

The Bigger Picture

Advances peptide/biomarker research.

What This Study Doesn't Tell Us

See abstract.

Questions This Raises

  • ?Further research needed.
  • ?Clinical translation to evaluate.

Trust & Context

Key Stat:
Key finding GH-releasing peptides in heart failure models improved cardiac contractility, reversed cachexia, suppressed stress hormones (norepinephrine, cortisol)
Evidence Grade:
preliminary evidence.
Study Age:
Published in 2005.
Original Title:
GH-releasing peptides improve cardiac dysfunction and cachexia and suppress stress-related hormones and cardiomyocyte apoptosis in rats with heart failure.
Published In:
American journal of physiology. Heart and circulatory physiology, 289(4), H1643-51 (2005)
Database ID:
RPEP-01102

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal StudyOne case or non-human subjects
This study

Tests effects in animals (usually mice or rats), not humans.

What do these levels mean? →

Frequently Asked Questions

What was studied?

GH-Releasing Peptides Improve Heart Function, Fight Cachexia, AND Reduce Heart Cell Death

What was found?

GH-releasing peptides improved cardiac dysfunction, reversed cachexia (muscle wasting), suppressed stress hormones, and reduced cardiomyocyte apoptosis in heart failure — demonstrating quadruple cardiac benefit.

Read More on RethinkPeptides

Cite This Study

RPEP-01102·https://rethinkpeptides.com/research/RPEP-01102

APA

Xu, Xiang-Bin; Pang, Jin-Jiang; Cao, Ji-Min; Ni, Chao; Xu, Rong-Kun; Peng, Xiao-Zhong; Yu, Xiao-Xia; Guo, Shu; Chen, Meng-Chin; Chen, Chen. (2005). GH-releasing peptides improve cardiac dysfunction and cachexia and suppress stress-related hormones and cardiomyocyte apoptosis in rats with heart failure.. American journal of physiology. Heart and circulatory physiology, 289(4), H1643-51.

MLA

Xu, Xiang-Bin, et al. "GH-releasing peptides improve cardiac dysfunction and cachexia and suppress stress-related hormones and cardiomyocyte apoptosis in rats with heart failure.." American journal of physiology. Heart and circulatory physiology, 2005.

RethinkPeptides

RethinkPeptides Research Database. "GH-releasing peptides improve cardiac dysfunction and cachex..." RPEP-01102. Retrieved from https://rethinkpeptides.com/research/xu-2005-ghreleasing-peptides-improve-cardiac

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.